Creative Medical launches Biodefense Inc. Veterans Initiative

Creative Medical (CELZ) Technology Holdings announced the official launch of its BioDefense Inc. Veterans Initiative, a national program to combat the devastating long-term effects of toxic burn pit exposure among U.S. service members The program will utilize Creative Medical’s proprietary iPSC and regenerative repair technologies and algorithms, coupled with AI-powered analytics, to identify, model, and reverse toxic-exposure-related disease pathways. BioDefense Inc., a subsidiary of Creative Medical, is spearheading the Burn Pit Exposure Molecular Characterization Program, designed to create one of the largest molecular-level databases of veteran toxic exposure in U.S. history. This platform will serve as the foundation for precision regenerative countermeasures, transforming the way respiratory, cardiovascular, and neurological damage from toxic exposure is diagnosed and treated. To execute this disruptive initiative, Greenstone Biosciences has been selected as the exclusive AI and iPSC development partner. Under this partnership, Greenstone will deploy advanced molecular-sequencing, proteomic profiling, and machine-learning algorithms to analyze cellular data from service members exposed to burn pits. These AI-integrated systems will accelerate the creation of predictive exposure models and precision-engineered regenerative therapies.